MD News

ICD therapy significantly reduces mortality in patients with moderate heart ...
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced results of the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 10-Year Follow-up Study at Heart Rhythm 2012, the Heart Rhythm Society's 33 rd Annual Scientific ...
St. Jude: ICD Therapy Improves Long-term Survival Of Patients With Heart FailureNASDAQ
HRS: ICD therapy shows benefit at long-term follow-upCardiovascular Business
10-year follow up study shows defibrillators improve patient mortalityMinneapolis Star Tribune (blog)

all 51 news articles »